Impact of mode of delivery on outcomes in patients with perianal Crohn's disease

Inflammatory Bowel Diseases

Volumn 20, Issue 8, 2014, Pages 1391-1398

  Cheng, Alice G ^a   Oxford, Emily C ^a   Sauk, Jenny ^a,b   Nguyen, Deanna D ^a,b   Yajnik, Vijay ^a,b   Friedman, Sonia ^b,c   Ananthakrishnan, Ashwin N ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

C section; Crohn's disease; Perianal fistula; Pregnancy

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; NATALIZUMAB; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANTIBIOTIC THERAPY; ANUS DISEASE; ARTICLE; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PELVIS INJURY; PERINEUM INJURY; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SMALL INTESTINE OBSTRUCTION; VAGINAL DELIVERY; VAGINAL INJURY; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; ELECTIVE SURGERY; MULTICENTER STUDY; OBSTETRIC DELIVERY; PATHOPHYSIOLOGY; PERINEUM; PREGNANCY COMPLICATION; PROGNOSIS; YOUNG ADULT;

ADULT; ANUS DISEASES; CASE-CONTROL STUDIES; CESAREAN SECTION; CROHN DISEASE; DELIVERY, OBSTETRIC; ELECTIVE SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; PERINEUM; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84905497735     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000093     Document Type: Article

References (23)

1. American Gastroenterological Association Clinical Practice C. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology. 2003;125:1503-1507.
2. Schwartz DA, Loftus EV Jr, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875-880.
3. Rankin GB, Watts HD, Melnyk CS, et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914-920.
4. Platell C, Mackay J, Collopy B, et al. Anal pathology in patients with Crohn's disease. Aust N Z J Surg. 1996;66:5-9.
5. Safar B, Sands D. Perianal Crohn's disease. Clin Colon Rectal Surg. 2007;20:282-293.
6. Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther. 2005;21:509-513.
7. Ferrero S, Ragni N. Inflammatory bowel disease: management issues during pregnancy. Arch Gynecol Obstet. 2004;270:79-85.
8. Friedman S, Regueiro MD. Pregnancy and nursing in inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:265-273, xii.
9. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease-a population-based cohort study. Am J Obstet Gynecol. 1997;177:942-946.
10. Mahadevan U, Cucchiara S, Hyams JS, et al. The London position statement of the World Congress of Gastroenterology on Biological therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol. 2011;106:214-223; quiz 224.
11. Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol. 2013;9:161-173; quiz 174.
12. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006;55(suppl 1):i36-i58.
13. Brandt LJ, Estabrook SG, Reinus JF. Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol. 1995;90:1918-1922.
14. Hatch Q, Champagne BJ, Maykel JA, et al. Crohn's disease and pregnancy: the impact of perianal disease on delivery methods and complications. Dis Colon Rectum. 2014;57:174-178.
15. Ilnyckyji A, Blanchard JF, Rawsthorne P, et al. Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol. 1999;94:3274-3278.
16. Rogers RG, Katz VL. Course of Crohn's disease during pregnancy and its effect on pregnancy outcome: a retrospective review. Am J Perinatol. 1995;12:262-264.
17. Smink M, Lotgering FK, Albers L, et al. Effect of childbirth on the course of Crohn's disease; results from a retrospective cohort study in the Netherlands. BMC Gastroenterol. 2011;11:6.
18. Nalichowski R, Keogh D, Chueh HC, et al. Calculating the benefits of a research patient data repository. AMIA Annu Symp Proc. 2006;1044.
19. de Silva PS, Nguyen DD, Sauk J, et al. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease. Aliment Pharmacol Ther. 2012;36:459-466.
20. Desai A, Zator ZA, de Silva P, et al. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:309-315.
21. Oxford EC, Nguyen DD, Sauk J, et al. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol. 2013;108:1123-1129.
22. Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-alpha therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014;38:385-391.
23. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.